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This paper summarizes two roundtable discussions held at the conclusion of the International Conference on Biopersistence of Respirable Synthetic
Fibres and Minerals. The first round table addressed the role of biopersistence in the pathogenicity of fiber-induced disease. The panel included
T. W. Hesterberg (Chairman), J.M.G. Davis, K. Donaldson, B. Fubini, N.F. Johnson, G. Oberdoerster, P. S6bastien, and D. Warheit. The second panel
addressed the issue of methods for assessing biopersistence. It included R.O. McClellan (Chairman), J. Brain, A. Langer, A. Morgan, C. Morscheidt,
H. Muhle, and R. Musselman. The two chairmen acknowledge the excellent contributions of all the members of the panels, whose comments
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Introduction
This article summarizes briefly available
scientific information on the role of biop-
ersistence in the pathogenicity of man-
made fibers and methods for evaluating
their biopersistence. In addition, at the end
of this article, we note some of the gaps in
our knowledge and make recommenda-
tions for future research.
Fiber biopersistence can be defined as
the retention in the lung, over time, of
fibers with regard to number, dimension,
surface chemistry, chemical composition,
surface area, and similar physical character-
istics. Changes in any of these parameters
may alter fiber toxicity. For this article, the
term "lung" is used to encompass the respi-
ratory airways, parenchyma, and the
pleura. Earlier articles in this volume docu-
ment the influence of fiber characteristics
on toxicity and carcinogenicity, and cover
in detail many of the points made here. A
summary of a Workshop on Evaluating the
Toxicity and Carcinogenicity of Man-
Made Fibers has also been published (1).
This paper was presented at the Workshop on
Biopersistence of Respirable Synthetic Fibers and
Minerals held 7-9 September 1992 in Lyon, France.
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Fibers can be eliminated from the lung
by bulk clearance, primarily involving
macrophage uptake and transport to the
mucociliary escalator, and by dissolution.
Mechanisms for translocation of fibers to
the pleura and the clearance offibers from
pleural spaces are not as well understood.
In vivo fiber instillation experiments have
demonstrated that short segments of man-
made vitreous fibers (MMVF) are more
readily removed from the lungs by
macrophages and mucociliary dearance than
longer fibers (2). The same phenomenon
has been demonstrated for chrysotile
asbestos following inhalation (3). It has also
been shown that fibers can be cleared from
terminal airways by epithelial cell uptake
(3), with subsequent translocation into the
interstitium and lymphatic system (4,5).
Fiber biopersistence is dependent upon
the site and rate ofdeposition, as well as on
rates of translocation, clearance, dissolu-
tion, and biomodification of the fiber in
the lung. It is quite possible that a change
in the rate of one of these processes could
affect the rates of other processes. For
example, a large increase in the rate of
deposition in the alveolar region could
potentially overwhelm macrophage clear-
ance mechanisms and increase the rate of
translocation to the lung interstitium. A
better understanding of the biological fate
of a fiber in the lung, which is dependent
upon all the various fiber characteristics, is
critical to understanding the mechanisms
underlying the differences in the toxic
potential of man-made fibers of different
compositions. Before focusing on bioper-
sistence, it is useful to review the factors
determining the deposition and biological
fate offibers in the lung.
Deposition
Fiber inhalation and deposition are the ini-
tial events in fiber-induced lung disease.
Fiber size and geometry are the determi-
nants ofboth host entry and intrapulmonic
distribution, and the essential determinant
of host entry is the aerodynamic diameter
of the fiber (6). Fibers having aerody-
namic diameters greater than 12 pm for
humans and 6 pm for rodents are not likely
to reach the bronchioles and alveoli ( 7).
Fibers with diameters less than or equal to
3 pm are considered respirable, even those
with lengths as great as 100 to 200 pm
(8,9). This is because the role of fiber
diameter, rather than length, is dominant
in determining aerodynamic diameter.
Fibers deposit mainly by impaction,
sedimentation, and interception; very little
is known about the role ofelectrostatic pre-
cipitation and diffusion in the deposition
of fibers (10). Both impaction and sedi-
mentation are governed by the aerody-
namic diameter of the fibers. Impaction is
favored byhigh airflow velocities and is the
predominant mechanism for fiber deposi-
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tion in large airways. In contrast, sedimen-
tation is favored by low flow velocity, long
residence time, and small airway size. The
role of interception increases with fiber
length (8).
Some authors have developed correla-
tions for the risk oflung cancer associated
with surface area, dimensions, and number
of asbestos fibers in the lung, since these
are the generally accepted determinants of
biopersistence (11), but such correlations
are not available for man-made fibers,
although biopersistence may also be an
important toxic determinant for them.
While fiber dimension determines the
entry and deposition in the lung,
biopersistence is critical for the accumu-
lation of fibers and for their continuing
bioreactivity.
Translocation and Clearance
After a fiber is deposited in the lung,
translocation or movement within the
lungs can occur. Fibers deposited in the
bronchoalveolar region can be translocated
to the ciliated epithelium for ultimate bulk
removal, or into epithelial cells lining the
alveoli and into the interstitium. Subse-
quently, fibers may be translocated along
lymphatic drainage pathways or remain
within the interstitium. If the fibers are
short enough, phagocytosis by macro-
phages may be involved in fiber transloca-
tion. Fiber dimensions influence translo-
cation, with fibers found at the pleura
being shorter and smaller in diameter than
those found in the central regions of the
lung (12).
Recent evidence suggests that the fate
and clearance ofinhaled fibers deposited in
the distal lung may be influenced by their
capacity to migrate from the alveolar to
interstitial compartments and that all types
of fibers do not translocate at the same
rate. In a recent inhalation study with
Kevlar aramid fibrils, rats were exposed to
fibrous aerosols for 1 week and evaluated
by electron and light microscopy at 24 hr
postexposure. Most Kevlar fibrils that had
deposited in the alveolar regions were
observed within alveolar macrophages.
Some macrophages that had phagocytized
fibrils adhered to Type I epithelial cells
(13), in contrast to previously observed
effects in the lungs of chrysotile asbestos-
exposed rats, where chrysotile fibers readily
translocated from airspaces through epithe-
lial cells to the interstitium (3). This dif-
ference may have significant implications
for lung clearance responses, as well as for
the development of interstitial fibrosis. It
seems likely that durable types of fibers
that translocate to interstitial compart-
ments will be cleared more slowly and may
be more fibrogenic, due in part to the
inability ofthese fibers to reach the alveolar
macrophages and the mucociliary escalator.
Moreover, fibers that reside for a longer
time within interstitial compartments may
contribute to pathogenic events underlying
the development of interstitial pulmonary
fibrosis. In contrast, nondurable fibers that
translocate from airspaces to the intersti-
tium may be cleared from the lung by dis-
solution processes in interstitial or
lymphatic compartments or within the
cytoplasm ofinterstitial macrophages.
Dissolution
Evidence of in vivo dissolution of MMVF
in the lungs has been extensively reviewed
(14,15). It has been demonstrated that the
dissolution ofinhaled MMVF is dependent
on fiber length, which may be due to dif-
ferences in extracellular and intracellular
pH and to the chemical composition ofthe
fibers (16,17). The relationship between
in vivo solubility and the chemical compo-
sition of inhaled fibers has been demon-
strated for a variety of MMVF, such as
refractory ceramic fibers (RCF), glass fiber,
rockwool, mineral wool, slagwool, chry-
sotile asbestos, and amphibole asbestos
(15-21). Their relative solubilities, set in
decreasing order, are glass fiber, slagwool >
rockwool > RCF > chrysotile asbestos >
amphibole asbestos. Their toxicological
potentials appear to increase in the same
order.
Chronic Inhalation Studies
Relatively few long-term inhalation studies
with either naturally occurring or man-
made fibers have been conducted (1).
Fortunately, new technology for conduct-
ing such exposures, as described elsewhere
(22-24), provides the opportunity to con-
duct inhalation studies that meet standards
previously not attainable. In one chronic
inhalation study, the biological effects on
rats of long-term exposure to glass fibers
(FG) (23) were compared with the effects
of exposure to chrysotile asbestos and to
RCF (25). The glass fibers, which were of
similar composition to common building
insulation wools, produced no lung fibrosis
in the exposed rats even after 24 months at
a concentration of30 mg/m3, neither were
there any mesotheliomas nor any signifi-
cant increase in lung tumors. In contrast,
exposure to chrysotile and, to a lesser
extent, to RCF, resulted in lung fibrosis,
mesotheliomas, and a significant increase
in lung tumors.
These findings are significant because
observed lung burdens and dimensions of
FG were comparable to those of RCF 1-
exposed animals, yet FG did not induce
lung fibrosis or tumors. This suggests that
internal dose and dimension are not suffi-
cient to explain the toxic potential of two
chemically different types of fibers.
Chemical composition and surface physic-
ochemical properties also may be impor-
tant determinants of fiber toxicity for
similarly sized fibers. The importance of
other fiber characteristics, such as chemical
composition, surface charge, and biological
persistence as determinants offiber toxicity
is nowwell recognized (1,15,20,22).
Methodological Issues
It is important to consider methodological
issues related to the administration of the
test material and to the recovery of fibers
from lung tissue to study the lung burden,
biopersistence, and toxicity of fibers.
Although intratracheal instillation permits
precise dosage and is economical, the suit-
ability ofthis model for fiber toxicity eval-
uation is still debatable. Distribution and
deposition patterns within the lung airways
after intratracheal instillation may not be
the same as after inhalation. For example,
intratracheal instillation of suspended
fibers can result in granulomas containing
fibers in the upper airways (bolus effect),
although this was overcome by using fiber
suspensions at low concentrations (18).
Validation by a comparison of instillation
and inhalation studies is certainly neces-
sary, and intracavitary administration of
fibers should also be included in the com-
parisons.
The low durability of MMVF in com-
parison to asbestos poses special problems
in the storage of exposed lung tissue and
subsequent fiber recovery. Storage in a fix-
ative oftissue containing MMVF can alter
the chemical composition of the fiber
(26), as can some wet tissue digestion
techniques, which can also alter physical
dimensions of fibers (27). Techniques
need to be developed that are appropriate
for each fiber composition, and wet diges-
tion techniques require special caution in
the selection of reagents. We believe that
the preferred technique for recovering
MMVF from lung tissue should start with
immediate freezing ofthe tissue for storage.
The recovery process would then involve
thawing the tissue, followed by rapid dehy-
dration with acetone, low temperature ash-
ing, and then rapid dispersion in distilled
water, followed by immediate collection
onto filters for microscopic analysis. In any
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Figure 1. Schematic representation ofmechanisms offiber-induced disease.
case, validation would be essential for any
proposed technique.
Summary of Knowledge
We have attempted here to summarize the
current state ofknowledge ofthe biopersis-
tence ofman-made fibers in the respiratory
tract and the consequent biological
response. This body of information rests
not just on the small number of investiga-
tions conducted with relatively few man-
made fibers, but also on the more extensive
knowledge obtained from studies of
asbestos fibers. A general representation of
the mechanisms by which fibers, such as
certain types ofasbestos, induce pulmonary
disease is shown in Figure 1. Although
man-made fibers have been less well stud-
ied, it is presumed that those that cause
disease operate by similar mechanisms. Not
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Our interest in biopersistence is twofold.
First, an understanding of the biopersis-
tence ofman-made fibers is essential to an
understanding ofthe mechanisms bywhich
inhaled fibers may or may not cause cancer
or other diseases of the respiratory tract.
Second, given that biopersistence has a sig-
nificant role in the pathogenesis of fiber-
induced diseases, including cancer,
evaluation of biopersistence may provide
useful surrogate marker(s) for evaluating
the disease-causing potential of any man-
made fibers being considered for introduc-
tion to commerce. Obviously, the ideal
Man-Made
Fibers
Figure 2 Interrelationship among information acquired from epidemiological studies ofasbestos-exposed people, labo-
ratorystudiesforasbestos, and man-madefibers and estimated human riskfrom man-madefibers.
would be a complete understanding ofhow
inhaled fibers cause disease and the identi-
fication of all necessary and sufficient
steps, including those relating to biopersis-
tence. With that level of knowledge, it
would then be possible to develop proce-
dures to evaluate the potential ofany fiber
to initiate anyofthose steps.
Unfortunately, our present knowledge
of the mechanisms by which fibers cause
disease is incomplete; moreover, it has
emerged primarily from studies ofasbestos-
exposed people and laboratory studies with
various kinds of asbestos and man-made
fibers (Figure 1). Our confidence in this
schematic model as a descriptor for
asbestos is greatly strengthened by actual
observations of human disease as the end-
points ofconcern-pleural and lung fibro-
sis, bronchogenic carcinomas and meso-
theliomas. Similar diseases have been
observed in asbestos-exposed laboratory
animals, which, in a sense, validates the
laboratory animal model. A paradigm for
extending our knowledge to man-made
fibers is shown in Figure 2. The aim is to
study man-made fibers and apply the
knowledge gained early enough to establish
appropriate control procedures that would
prevent fiber-induced disease in people and
so, fortunately, limit the potential for
observing the effects on humans.
The development of more structured
exposure-dose-response models is most neces-
sary (Figure 3), as well as validated experi-
mental systems in which the end diseases of
concem observed in laboratory animals could
beconfidentlyextrapolated to humans.
For man-made fibers, the nature ofthe
data base associating exposure and disease
is incondusive, so that it is not possible to
validate animal experiments or other labo-
ratory studies by comparing results with
demonstrated effects in exposed humans.
Fortunately, the various methods ofevalua-
tion have been indirectly validated, by ref-
erence to the data bases available on
asbestos. Ifdisease were observed in labora-
tory animals exposed to man-made fibers,
this would need to be viewed as a positive
indicator ofthe potential health hazard for
man. Conversely, while the absence ofdis-
ease in well-conducted studies with labora-
tory animals exposed to man-made fibers
cannot be used as evidence for a lack of
hazard for man ifsimilarly exposed, it cer-
tainly supports ofthis conclusion.
This viewpoint is summarized schemat-
ically in Figures 4 and 5. In Figure 4, each
step in the multistep process leading to an
adverse disease outcome may serve as the
basis for an evaluation procedure and a





















Figure3. Role ofmechanistic data as a basefordeveloping exposure-response models.
number of these steps relate to biopersis-
tence. For example, can the fiber be
inhaled and deposited? Do the fibers dis-
solve rapidly? Do certain chemical con-
stituents selectively leave the fibers? Do the
fibers change in physical dimensions? Are
the fibers cleared by physical transport
processes from the lungs? Do the fibers
translocate to the pleural surfaces? Do the
fibers enter target cells? Are the fibers cyto-
toxic to target cells? Do the fibers cause





Steps in the c
questions can be studied in detail in experi-
mental systems with the expectation that
the answers can ultimately be extrapolated
to human populations (Figure 5).
This long list of questions is by no
means complete, which is, in itself, a
reflection of our level of knowledge of
fiber-induced disease. Moreover, many of
the processes involved would not yield a
yes or no answer but rather fall within a
continuum, for example between slow and
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+/1, the presence (+) or absence (-) of a given step or the end disease
(a), presumptive positive evidence for human carcinogenicity
(b), presumptive negative evidence for human carcinogenicity
Figure 4. Validation offiber evaluation proceduresforestimating human health risks.
+
that any single evaluation procedure related
to biopersistence will provide a yes or no
answer about the potential ofa test fiber to
cause cancer. It is important to consider
the outcome of any evaluation procedure
in a quantitative, probabilistic manner,
including taking account ofthe dose oftest
material administered. Certain carcino-
genicity studies can be considered to illus-
trate this point.
It is generally agreed that the greater
the durability of a fiber type, the greater
is its likelihood of causing disease. Con-
versely, the lower the durability, the lower
is the disease-causing potential, so that
fibers that dissolve relatively rapidly should
have lower potential for causing disease.
In a test of an experimental fiber of
moderately high solubility by intracavitary
instillation in rats, tumors were observed
only at very high dose level (30). Interpre-
tation ofthis result must take into account
the mode of administration as well as the
dose administered, but would suggest that
even soluble fibers might be carcinogenic if
the fiber dose were high enough. Special
care is required in making such an interpre-
tation based on a single, and perhaps overly
simplified, procedure.
These considerations also point to the
need to shift our orientation from asking
whether the material is carcinogenic to ask-
ing what is the potential cancer risk at
anticipated levels ofhuman exposure. This
kind oforientation is inherent in the use of
exposure-response models (Figure 3). It
also requires careful consideration oflikely
human exposure circumstances throughout
the product life cycle (Figure 6). The fiber
level and characteristics used in experimen-
tal studies should be linked to the fiber
level and characteristics at each stage of
potential human exposure. This should be
borne in mind, for example, where fiber
samples are subjected to size separation
prior to experimental use, to obtain a
higher proportion of respirable fibers than
would probably be encountered in the
occupational or environmental setting.
Tiered Approach
+ (a) To obtain information on new fibers as
quickly as possible and to keep testing costs
_ (b) moderate, a tiered approach to evaluating
new fibers was recommended by partici-
pants in a previous workshop (1). This
approach (Figure 7) has the advantage that
the first steps can be completed at low cost
and within months, in contrast to the con-
duct of long-term inhalation studies that
would be expensive and require a mini-

























Figure5. Critical linkages in understanding potential toxicityandcarcinogenicity ofman-madefibers.
tiered approach, a number of test fibers
could be evaluated with the first few steps,
which might then identify some fibers that
have unfavorable characteristics and
responses that suggest such a high potential
for toxicity or carcinogenicity that it would
be inappropriate to consider further com-
mercial development, especially ifthe fiber
product cycle is likely to involve significant
human exposure. Conversely, it may also
ultimately be possible to identify early in
the screening tiers those fibers that have
favorable characteristics and negative
responses indicating that they would pre-
sent a minimal potential hazard, thus obvi-
ating the need for further evaluation.
Unfortunately, the level of confidence in
the screening procedures is, at present, not
sufficient to permit this course of action,
and it is necessary to evaluate fibers in
long-term inhalation studies if they have
high potential for commercial use and if
the product life cycle indicates the likeli-
hood ofhuman exposure.
There has been extensive and vigorous
discussion at this conference on the role of
long-term inhalation studies versus intra-
cavitary injection studies for hazard identi-
Life Cycle of Fiber Product
Production - Use - Disposal
Samples of Fibers





Figure6. Relating characteristics offibers studied backto
characteristics offibersduring product lifecycle.
fication or risk characterization. Most sci-
entists view inhalation as the preferred
route ofexposure, since it simulates human
exposures and results in fibers reaching the
target tissues at an appropriate rate relative
to potential human exposures. Others (31)
advocate use of intracavitary injection to
assure that a maximum number of fibers
reaches one ofthe target tissues, the pleura;
they consider that the inhalation route is
not sufficiently sensitive for detection of
the neoplasms of concern, which have a
long latent period. Conversely, the criti-
cism is made that the intracavitary studies
yield false-positive findings because high
levels of exposure result from delivery of a
bolus or a series ofboli offibers to the cav-
ity. The boli overwhelm normal defense




The most critical research needs are for the
acquisition ofinformation that will provide
mechanistic linkages between exposure and
dose, and between dose and response
(Figure 3). To be most useful, this should
include information acquired from studies
conducted at multiple exposure levels and
durations, so that convincing evidence may
be obtained as to the likely mechanisms of
action at relevant potential human expo-
sure levels.
There is, first ofall, need for improved
techniques for characterizing fiber expo-
sures, including both potential human
exposure circumstances within a product
life cycle and experimental exposures
(Figure 6). It will be especially useful to
develop techniques to characterize fibers
not only by their dimensions, as has been
traditional, but also by surface area and
chemistry, which may have special toxico-
logical relevance.
Second, there is a critical need for
improved information on the disposition
ofinhaled fibers both in laboratory animals
and humans. Much of our current under-
standing has been derived indirectly from a
much more abundant knowledge base
relating to inhaled particles. The tech-
niques are now at hand to develop a similar
body ofexperimental data on the influence
of fiber diameter and length on initial
deposition and clearance of fibers. Such
data are needed on the more frequently
used laboratory animal species and, ideally,
on people, to enhance our ability to make
extrapolations from laboratory animals
(Figure 2). The emerging technology
should make it possible to obtain much
more detailed knowledge on the clearance
of fibers ofvaried size and chemical com-
position, and to develop models of the
regional fate of fibers in the lung and the
relative role ofphysical removal and ofdis-
solution. Once the models have been vali-
dated, it will be possible to consider "dose
terms" that move beyond the total lung to
specific regional tissues and cells.
Third, we need research to link our
emerging knowledge of fiber dosimetry
with the various steps in the pathogenesis
of fiber-induced disease, and to develop a
better understanding of the relationship of
results obtained in vitro to in vivo observa-
nIr Approach
I Product life cycle evaluation
Physical characterization
length & diameter
surface area (both intemal and extemal)
Chemical composition




























Figure 7. Tiered approach to characterizing toxicity and
carcinogenicity ofnewfibers.
Volume 102, Supplement 5, October 1994 281McCLELLANAND HESTERBERG
tions, extending over the life-span of the
laboratory animal species up to the appear-
ance of neoplastic diseases. It would be
especially useful if comparative studies
could be conducted with carcinogenic and
noncarcinogenic materials. This approach
(Figure 4) would help to identify the criti-
cal steps in the process offiber carcinogen-
esis. Particular attention still needs to be
given to understanding the relevance of
observations made with the different mod-
els of fiber administration-intracavitary
or intratracheal or by inhalation. The con-
tinuing debate over the assertions that
inhalation studies yield false negatives and
that intracavitary studies yield false posi-
tives must be resolved.
Finally, we need continued develop-
ment of improved models (Figure 3) to
describe in quantitative terms the relation-
ships between exposure and dose and
response that are based on a sound under-
standing of the biology and pathobiology
of the systems being described. Models
have great potential not only for integrat-
ing and synthesizing what is known but
also for identifying deficiencies in our
knowledge that may be removed through
targeted experimentation.
Research Related to Biopersistence
A number of issues related more specifi-
cally to biopersistence have already been
discussed. The concept ofbiopersistence-
the retention of fibers in the lung over
time-is evidently an important determi-
nant of the toxicity and carcinogenicity of
fibers; yet our current knowledge ofits sig-
nificance and the lack of standardized
approaches for assessing it are major
impediments to using information on
biopersistence to make decisions on the
potential hazard of a given fiber type.
Research on factors such as fiber number,
dimension, surface chemistry, chemical
composition, surface area, and other para-
meters that influence biopersistence will
change this situation, taking advantage of
life-span in vivo studies with different
kinds ofman-made fibers that have yielded
both positive and negative carcinogenic
results (Figure 4, test fibers A and B).
Studying the various steps in the underly-
ing biological processes and how they relate
to the physical and chemical characteristics
of the fibers will help us to understand
which of these characteristics are essential
to the carcinogenesis process.
The prospects for progress will be fur-
ther enhanced as more man-made fibers
are evaluated in life-span in vivo bioassays,
of comparable quality to those recently
conducted, and in which it will be espe-
cially important to understand as com-
pletely as possible the full exposure-
dose-response paradigm. In addition to
studies with man-made fibers, animal life-
span-bioassay studies with asbestos fibers
of different types using contemporary
inhalation exposure technology and meth-
ods will be of unique value. They would
provide a linkage to the data base acquired
from epidemiological studies of asbestos-
exposed populations (Figures 2,4). With
these approaches, it should be possible in
the not-too-distant future to identify char-
acteristics of biopersistence linked to the
carcinogenicity of fibers that would be
evaluated in short-to-intermediate-term
studies and so could serve as indicators of
the carcinogenic potential of newly devel-
oped fibers. The degree of confidence in
these indicators will depend on the extent
to which the assay systems have been vali-
dated by comparing fibers that produce
cancer with those that do not.
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